Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide
2007

Squalestatin's Effect on Neurotoxic Prion Peptide Trafficking

publication Evidence: moderate

Author Information

Author(s): Wilson Rona, Bate Clive, Boshuizen Ronald, Williams Alun, Brewer James

Primary Institution: University of Glasgow

Hypothesis

The neurotoxicity of the prion peptide MoPrP105-132 is dependent on its intracellular trafficking pathways.

Conclusion

Squalestatin treatment alters the trafficking of the neurotoxic prion peptide, leading to increased cell survival.

Supporting Evidence

  • MoPrP105-132 co-localised with lipid raft markers and trafficked intracellularly within lipid rafts.
  • Squalestatin treatment reduced neuronal cholesterol levels and altered the peptide's trafficking.
  • Treatment with squalestatin increased cell survival by rerouting the peptide to lysosomes.

Takeaway

This study shows that a drug called squalestatin can change how a harmful protein moves inside brain cells, helping the cells survive better.

Methodology

The study used fluorescence microscopy and cell fractionation techniques to analyze the trafficking of the MoPrP105-132 peptide in neuroblastoma cells.

Statistical Information

Statistical Significance

p>0.05

Digital Object Identifier (DOI)

10.1186/1471-2202-8-99

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication